Tert-Butyl 3-oxoazetidine-1-carboxylate

Tert-Butyl 3-oxoazetidine-1-carboxylate is a synthetic intermediate. tert-Butyl 3-oxoazetidine-1-carboxylate is used in the discovery and development of compounds targeting cancer and tuberculosis[1][2][3].

Product Specifications

CAS Number

[398489-26-4]

Product Name Alternative

N-Boc-3-azetidinone

UNSPSC

12352200

Hazard Statement

H302, H315, H318, H335

Target

Biochemical Assay Reagents; Drug Intermediate

Type

Biochemical Assay Reagents

Related Pathways

Others

Field of Research

Cancer; Infection; Others

Assay Protocol

https://www.medchemexpress.com/tert-butyl-3-oxoazetidine-1-carboxylate.html

Purity

99.99

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(OC(C)(C)C)N1CC(C1)=O

Molecular Formula

C8H13NO3

Molecular Weight

171.19

Precautions

H302, H315, H318, H335

References & Citations

[1]Robles O, et al. Novel Piperidinyl-Azetidines as Potent and Selective CCR4 Antagonists Elicit Antitumor Response as a Single Agent and in Combination with Checkpoint Inhibitors. J Med Chem. 2020 Aug 13;63 (15) :8584-8607.|[2]Bradbury RH, et al. Optimization of a Series of Bivalent Triazolopyridazine Based Bromodomain and Extraterminal Inhibitors: The Discovery of (3R) -4-[2-[4-[1- (3-Methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl) -4-piperidyl]phenoxy]ethyl]-1,3-dimethyl-piperazin-2-one (AZD5153) . J Med Chem. 2016 Sep 8;59 (17) :7801-17.|[3]Komarova K, et al. The Nitrofuran-Warhead-Equipped Spirocyclic Azetidines Show Excellent Activity against Mycobacterium tuberculosis. Molecules. 2024 Jun 27;29 (13) :3071.